DIPLOID PREDOMINANCE AND PROGNOSTIC-SIGNIFICANCE OF S-PHASE CELLS IN MALIGNANT MESOTHELIOMA

被引:27
作者
PYRHONEN, S
LAASONEN, A
TAMMILEHTO, L
RAUTONEN, J
ANTTILA, S
MATTSON, K
HOLSTI, LR
机构
[1] UNIV HELSINKI,CENT HOSP,DEPT PULM MED,SF-00290 HELSINKI 29,FINLAND
[2] UNIV HELSINKI,CENT HOSP,DEPT MICROBIOL IMMUNOL,SF-00290 HELSINKI 29,FINLAND
[3] INST OCCUPAT HLTH,SF-00290 HELSINKI 29,FINLAND
关键词
D O I
10.1016/0277-5379(91)90487-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
70 histologically verified, malignant mesotheliomas were analysed by flow cytometry for DNA content and S-phase fraction (SPF) of tumour cells. 60% (42/70) were DNA diploid. 18 of the 28 aneuploid tumours were near-diploid with DNA indices of 1.3 or less. SPF could be calculated in 51 cases. SPF was significantly higher in aneuploid (median 16.0%) than in diploid tumours (median 5.6%). DNA ploidy was not a prognostic determinant; survival was the same for both aneuploid and diploid tumours. SPF, however, was significantly correlated (P = 0.039) with prognosis. Patients who had tumours with a low SPF survived almost twice as long as those with a high SPF. Thus malignant mesothelioma has a peculiar DNA ploidy pattern compared with many other solid tumours, with a predominance of diploid or near-diploid type cells. As in many other tumours, SPF may be used as a clinically relevant prognostic indicator.
引用
收藏
页码:197 / 200
页数:4
相关论文
共 35 条
[1]  
ABE S, 1987, ANAL QUANT CYTOL, V9, P425
[2]  
ADAMS VI, 1986, CANCER, V58, P1540, DOI 10.1002/1097-0142(19861001)58:7<1540::AID-CNCR2820580727>3.0.CO
[3]  
2-5
[4]   MALIGNANT PLEURAL MESOTHELIOMA - A DISEASE UNAFFECTED BY CURRENT THERAPEUTIC MANEUVERS [J].
ALBERTS, AS ;
FALKSON, G ;
GOEDHALS, L ;
VOROBIOF, DA ;
VANDERMERWE, CA .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) :527-535
[5]   ANALYSIS OF PCP-DATA TO DETERMINE FRACTION OF CELLS IN VARIOUS PHASES OF CELL-CYCLE [J].
BAISCH, H ;
GOHDE, W ;
LINDEN, WA .
RADIATION AND ENVIRONMENTAL BIOPHYSICS, 1975, 12 (01) :31-39
[6]  
BUCHNER T, 1985, PATHOL RES PRACT, V179, P310
[7]   FLOW CYTOMETRIC ANALYSIS OF MALIGNANT PLEURAL MESOTHELIOMAS [J].
BURMER, GC ;
RABINOVITCH, PS ;
KULANDER, BG ;
RUSCH, V ;
MCNUTT, MA .
HUMAN PATHOLOGY, 1989, 20 (08) :777-783
[8]   FLOW CYTOFLUOROMETRIC EVIDENCE FOR THE DIFFERENTIAL RADIORESPONSIVENESS OF ANEUPLOID AND DIPLOID CERVIX TUMORS [J].
DYSON, JED ;
JOSLIN, CAF ;
ROTHWELL, RI ;
QUIRKE, P ;
KHOURY, GG ;
BIRD, CC .
RADIOTHERAPY AND ONCOLOGY, 1987, 8 (03) :263-272
[9]   PREOPERATIVE IRRADIATION IN ORAL CAVITY CARCINOMA - A STUDY WITH SPECIAL REFERENCE TO DNA PATTERN, HISTOLOGICAL RESPONSE AND PROGNOSIS [J].
FRANZEN, G ;
OLOFSSON, J ;
TYTOR, M ;
KLINTENBERG, C ;
RISBERG, B .
ACTA ONCOLOGICA, 1987, 26 (05) :349-355
[10]   FLOW CYTOMETRIC ANALYSIS OF PLOIDY IN IMMUNOHISTOCHEMICALLY CONFIRMED EXAMPLES OF MALIGNANT EPITHELIAL MESOTHELIOMA [J].
FRIERSON, HF ;
MILLS, SE ;
LEGIER, JF .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1988, 90 (03) :240-243